Raymond James & Associates Bio N Tech Se Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Bio N Tech Se stock. As of the latest transaction made, Raymond James & Associates holds 2,541 shares of BNTX stock, worth $287,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,541

Previous 2,799 9.22%

Holding current value

$287,336

Previous $224,000 34.38%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$78.36 - $124.66 $20,216 - $32,162	-258 Reduced 9.22%	2,541 $301,000
Q2 2024 Jul 19, 2024	BUY	$80.36 - $102.87 $28,126 - $36,004	350 Added 14.29%	2,799 $224,000
Q1 2024 Apr 22, 2024	SELL	$88.96 - $112.35 $21,439 - $27,076	-241 Reduced 8.96%	2,449 $225,000
Q4 2023 Jan 16, 2024	SELL	$90.91 - $112.75 $262,638 - $325,734	-2,889 Reduced 51.78%	2,690 $283,000
Q3 2023 Oct 24, 2023	BUY	$98.5 - $125.08 $29,353 - $37,273	298 Added 5.64%	5,579 $606,000
Q2 2023 Jul 25, 2023	SELL	$102.58 - $129.66 $511,566 - $646,614	-4,987 Reduced 48.57%	5,281 $569,000
Q1 2023 Apr 14, 2023	SELL	$122.57 - $153.67 $490,402 - $614,833	-4,001 Reduced 28.04%	10,268 $1.28 Million
Q4 2022 Feb 08, 2023	SELL	$118.43 - $186.05 $721,830 - $1.13 Million	-6,095 Reduced 29.93%	14,269 $2.14 Million
Q3 2022 Oct 25, 2022	SELL	$127.65 - $183.11 $339,293 - $486,706	-2,658 Reduced 11.55%	20,364 $2.75 Million
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $350,399 - $529,480	-2,843 Reduced 10.99%	23,022 $3.43 Million
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $1.9 Million - $3.48 Million	-15,019 Reduced 36.74%	25,865 $4.41 Million
Q4 2021 Feb 08, 2022	BUY	$216.64 - $362.52 $1.26 Million - $2.1 Million	5,796 Added 16.52%	40,884 $10.5 Million
Q3 2021 Nov 02, 2021	BUY	$205.93 - $447.23 $2 Million - $4.34 Million	9,704 Added 38.23%	35,088 $9.58 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $686,832 - $1.46 Million	6,061 Added 31.37%	25,384 $5.68 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $1.4 Million - $1.96 Million	16,367 Added 553.69%	19,323 $2.11 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $214,930 - $382,920	2,956 New	2,956 $241,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Bio N Tech Se Transaction History